New York, April 8–10, 2025

For three days, Math Biology took part in the Italian-American Business Forum, representing one of 20 selected startups from the Lazio region.
The mission? To spark transatlantic collaborations across life sciences, AI, aerospace, and beyond.

But behind the meetings and panels, something deeper unfolded.
It was about connections. About alignment of values. About seeing how a human-centered approach to science can cross borders and inspire new futures.

From Rome to New York: Listening to Metabolism, Globally

Math Biology was founded to make the invisible visible — to detect early metabolic imbalances before disease strikes, through a technology called DMA® (Deep Metabolic-processes Assessment).

In New York, we shared that mission with researchers, investors, policymakers, and fellow innovators. We talked not just about what DMA® does — but why it matters.
Because when you can hear the body’s early signals, you don’t wait for illness.
You act, you adapt, you prevent.

Real Conversations. Real Opportunity.

Over the course of the event:

• We joined expert roundtables on digital health and AI
• We presented our vision for global partnerships
• We met stakeholders who believe, as we do, that precision and prevention are the future

The forum wasn’t just about Math Biology pitching.
It was about listening — to the needs of the healthcare system, to the urgency of transformation, to the potential of cross-continental synergy.

Looking Ahead

This milestone marks the start of a new chapter.

We’re building bridges — between continents, disciplines, and communities.
Between early detection and real-world impact.
Between data and trust.

New York reminded us that the conversation around health is changing.
It’s becoming earlier. Smarter. More human.